The closing of many transactions, as well as the completion of Lorient Healthcare Fund II (Fund II), at a hard cap of $225 million was announced by Lorient Capital Management. Fund II was oversubscribed.
In 2021, Lorient has completed two new platform investments and one recapitalization worth more than $100 million in equity co-investment, as well as commitments from Fund II. Since closing on its first fund in 2018, Lorient has completed 7 new platform investments, over 30 tuck in acquisitions, and 5 exits/recapitalizations.
The Lorient Group is a private investment firm with expertise exclusively in healthcare. Our approach, which incorporates our entrepreneurial, operational, and investment experience, results in industry-leading healthcare services and technology businesses.
Kaitlin Welch manages to cover anything. She is our freelance contributor. Kristie is responsible for covering reporting in finance and business News categories. Kaitlin has experience of 5 years as a reporter to News insights. Kaitlin writes related to the News Category.
